MAPT and early-onset autosomal dominant Alzheimer disease: For example, recent research has highlighted the relationship between CVR measures and various aspects of cognitive and physical function, independent of Alzheimer’s disease pathologies such as tau, phosphorylated tau, and amyloid-beta (Aβ) (Sur et al., 2020, 2024; Taneja et al., 2020).